Barry Heller is the principal investigator at Long Beach Clinical Trials in Long Beach, Calif. He administered the first-in-the-U.S. doses of monoclonal antibodies to patients with COVID-19 infections. He was a lead author in the October 28, 2020 issue of the New England Journal of Medicine article “SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.”
See more notes:
Class of 1975